MedPath

Phytoestrogen dietary supplementation in post-menopausal women with type two diabetes: effects on glycaemic control, insulin resistance and indices of cardiovascular risk. A cross over trial

Completed
Conditions
Type two diabetes in post-menopausal women
Nutritional, Metabolic, Endocrine
Diabetes mellitus
Registration Number
ISRCTN75939563
Lead Sponsor
Hull University (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
36
Inclusion Criteria

1. Post-menopausal women (amenorrhoea for at least 12 months)
2. Type two diabetes on diet alone as a form of treatment

Exclusion Criteria

1. Secondary causes of impaired glucose tolerance such as hypercortisolemia
2. No hormone replacement or stopped at least six weeks prior recruitment
3. Uncontrolled hypothyroidism (if receiving thyroid hormone replacement, the patient should be euthyroid with Thyroid Stimulating Hormones [TSH] less than 5.0 mU/L)
4. Blood pressure more than 160/90 mmHg
5. Recent initiation of statin treatment/dose modification (less than four weeks)
6. Patients not wishing to allow disclosure to General Practitioners (GPs)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Modification of glycaemic parameters<br>2. Modification of indices of cardiovascular risk
Secondary Outcome Measures
NameTimeMethod
1. Alteration in renal function<br>2. Alteration in endogenous sex hormones
© Copyright 2025. All Rights Reserved by MedPath